lncRNA and breast cancer: Progress from identifying mechanisms to challenges and opportunities of clinical treatment
Breast cancer is a malignant tumor that has a high mortality rate and mostly occurs in women. Although significant progress has been made in the implementation of personalized treatment strategies for molecular subtypes in breast cancer, the therapeutic response is often not satisfactory. Studies ha...
Main Authors: | Huan Jin, Wei Du, Wentao Huang, Jiajing Yan, Qing Tang, Yibing Chen, Zhengzhi Zou |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2021-09-01
|
Series: | Molecular Therapy: Nucleic Acids |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2162253121001992 |
Similar Items
-
LncRNA GAS8‐AS1 downregulates lncRNA NEAT1 to inhibit glioblastoma cell proliferation
by: Xiaoming Wu, et al.
Published: (2021-06-01) -
Overexpression of lncRNA IGFBP4–1 reprograms energy metabolism to promote lung cancer progression
by: Binyao Yang, et al.
Published: (2017-09-01) -
Overexpression of lncRNA PTENP1 suppresses glioma cell proliferation and metastasis in vitro
by: Hu S, et al.
Published: (2018-12-01) -
LncRNA MANCR positively affects the malignant progression of lung adenocarcinoma
by: Chang Liu, et al.
Published: (2021-08-01) -
Biomarker potential of lncRNA GNAS-AS1 in osteosarcoma prognosis and effect on cellular function
by: Zhanhu Mi, et al.
Published: (2021-07-01)